NasdaqCM - Nasdaq Real Time Price USD
VYNE Therapeutics Inc. (VYNE)
1.8400
-0.0200
(-1.08%)
At close: April 23 at 4:00:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| DOMZALSKI DAVID T Chief Executive Officer | Stock Award(Grant) | Nov 29, 2024 | 500,597 |
| HARSCH MUTYA FONTE General Counsel | Stock Award(Grant) | Dec 29, 2023 | 149,435 |
| LEPORE PATRICK G Director | Purchase | Jan 15, 2025 | 51,472 |
| STUART IAIN A Officer | Stock Award(Grant) | Dec 29, 2023 | 133,898 |
| ZERONDA TYLER Chief Financial Officer | Stock Award(Grant) | Dec 29, 2023 | 131,837 |
Related Tickers
ATXI Avenue Therapeutics, Inc.
0.2580
-4.44%
ELTX Elicio Therapeutics, Inc.
5.22
+3.37%
ERNA Ernexa Therapeutics Inc.
0.1938
+5.21%
ELVN Enliven Therapeutics, Inc.
17.77
-1.11%
GLYC GlycoMimetics, Inc.
0.2387
+4.69%
NTHI NeOnc Technologies Holdings, Inc. Common Stock
5.88
-2.00%
HTD.MU Corcept Therapeutics Inc
60.20
+5.73%
BT3.BE Lineage Cell Therapeutics Inc
0.4020
+8.06%
7AY1.F Actinium Pharmaceuticals, Inc.
1.1160
-6.92%
HQ1.MU Oruka Therapeutics Inc. R
9.15
+0.55%